1. Long-Term Outcomes of AML Patients Using Total Lymphoid Irradiation with Anti- Thymocyte Globulin 
Hideki Nakasone, MD, PhD, David B. Miklos, Everett Meyer, MD, PhD, Andrew Rezvani, Lori Muffly, MD, MS, Wen-Kai Weng, MD, Sally Arai, MD, Laura Johnston, MD, Ginna G. Laport, MD, Judith A. Shizuru, MD, PhD, Robert Negrin, MD, Samuel Strober, MD, Robert Lowsky, MD 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 3, Pages S204-S205 (March 2016)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 2
Relation between relapse and maximum of donor chimerism achieved by 6 months post-HST (%). *Three patients who experienced late graft loss with complete autologous hematopoietic recovery without disease relapse were excluded.
Biology of Blood and Marrow Transplantation  , S204-S205DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 1
Overall survival and proportion of alive patients with or without immunosuppressive agents.
Biology of Blood and Marrow Transplantation  , S204-S205DOI: ( /j.bbmt )
Copyright © Terms and Conditions